Steven Cohen’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.4K Buy
+18,819
New +$24.4K ﹤0.01% 3784
2026
Q2
– Sell
-20,945
Closed -$26K – 4460
2026
Q1
$26K Sell
20,945
-7,799
-27% -$9.9K ﹤0.01% 3680
2025
Q4
$35.9K Buy
+28,744
New +$38.5K ﹤0.01% 3805
2024
Q2
– Sell
-205,855
Closed -$350K – 2324
2024
Q1
$350K Sell
205,855
-544,298
-73% -$1.02M ﹤0.01% 1738
2023
Q4
$2.33M Buy
+750,153
New +$1.99M 0.01% 1152
2023
Q2
– Sell
-38,178
Closed -$182K – 2654
2023
Q1
$182K Buy
+38,178
New +$269K ﹤0.01% 1509

Other funds holding PMVP

Steven Cohen's PMVP Position: Q3 2026 in Review

Steven Cohen opened a new position in PMV Pharmaceuticals (PMVP) in Q3 2026: 18,819 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #3784 among its holdings. This is a return to the name: Steven Cohen previously reported a position in PMVP as recently as Q1 2026.

Steven Cohen first reported a position in PMVP in Q1 2023 and has held it in 6 quarters since. The position peaked at $2.33M in Q4 2023. 65 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Steven Cohen held 18,819 shares of PMV Pharmaceuticals worth $31.4K as of Q3 2026.
  • PMV Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3784 holding.
  • Steven Cohen first reported a position in PMV Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • Steven Cohen's PMV Pharmaceuticals position peaked at $2.33M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.